488 related articles for article (PubMed ID: 24267148)
1. Comparison of the efficacies of oral iron and pramipexole for the treatment of restless legs syndrome patients with low serum ferritin.
Lee CS; Lee SD; Kang SH; Park HY; Yoon IY
Eur J Neurol; 2014 Feb; 21(2):260-6. PubMed ID: 24267148
[TBL] [Abstract][Full Text] [Related]
2. Long-term open-label study of pramipexole in patients with primary restless legs syndrome.
Inoue Y; Kuroda K; Hirata K; Uchimura N; Kagimura T; Shimizu T
J Neurol Sci; 2010 Jul; 294(1-2):62-6. PubMed ID: 20451927
[TBL] [Abstract][Full Text] [Related]
3. Comparison of pregabalin with pramipexole for restless legs syndrome.
Allen RP; Chen C; Garcia-Borreguero D; Polo O; DuBrava S; Miceli J; Knapp L; Winkelman JW
N Engl J Med; 2014 Feb; 370(7):621-31. PubMed ID: 24521108
[TBL] [Abstract][Full Text] [Related]
4. A mixed treatment comparison of gabapentin enacarbil, pramipexole, ropinirole and rotigotine in moderate-to-severe restless legs syndrome.
Sun Y; van Valkenhoef G; Morel T
Curr Med Res Opin; 2014 Nov; 30(11):2267-78. PubMed ID: 25050588
[TBL] [Abstract][Full Text] [Related]
5. Effect of pramipexole on RLS symptoms and sleep: a randomized, double-blind, placebo-controlled trial.
Ferini-Strambi L; Aarskog D; Partinen M; Chaudhuri KR; Sohr M; Verri D; Albrecht S
Sleep Med; 2008 Dec; 9(8):874-81. PubMed ID: 18952497
[TBL] [Abstract][Full Text] [Related]
6. Iron for the treatment of restless legs syndrome.
Trotti LM; Becker LA
Cochrane Database Syst Rev; 2019 Jan; 1(1):CD007834. PubMed ID: 30609006
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of oral iron in patients with restless legs syndrome and a low-normal ferritin: A randomized, double-blind, placebo-controlled study.
Wang J; O'Reilly B; Venkataraman R; Mysliwiec V; Mysliwiec A
Sleep Med; 2009 Oct; 10(9):973-5. PubMed ID: 19230757
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of pramipexole in Japanese patients with primary restless legs syndrome: A polysomnographic randomized, double-blind, placebo-controlled study.
Inoue Y; Hirata K; Kuroda K; Fujita M; Shimizu T; Emura N; Uchimura N; Kagimura T; Sha K; Nozawa T
Sleep Med; 2010 Jan; 11(1):11-6. PubMed ID: 19962941
[TBL] [Abstract][Full Text] [Related]
9. Efficacy, safety and dose-response of pramipexole in Japanese patients with primary restless legs syndrome: randomized trial.
Inoue Y; Kuroda K; Hirata K; Uchimura N; Kagimura T; Shimizu T
Neuropsychobiology; 2011; 63(1):35-42. PubMed ID: 21063131
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of pramipexole in chinese patients with restless legs syndrome: results from a multi-center, randomized, double-blind, placebo-controlled trial.
Ma JF; Wan Q; Hu XY; Sun SG; Wang WZ; Zhao ZX; Wang YJ; Liu CF; Li JM; Jiang YP; Chen SD
Sleep Med; 2012 Jan; 13(1):58-63. PubMed ID: 22137119
[TBL] [Abstract][Full Text] [Related]
11. Ropinirole in patients with restless legs syndrome and baseline IRLS total scores ≥ 24: efficacy and tolerability in a 26-week, double-blind, parallel-group, placebo-controlled study followed by a 40-week open-label extension.
Giorgi L; Asgharian A; Hunter B
Clin Ther; 2013 Sep; 35(9):1321-36. PubMed ID: 23938061
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of pramipexole in restless legs syndrome: a six-week, multicenter, randomized, double-blind study (effect-RLS study).
Oertel WH; Stiasny-Kolster K; Bergtholdt B; Hallström Y; Albo J; Leissner L; Schindler T; Koester J; Reess J;
Mov Disord; 2007 Jan; 22(2):213-9. PubMed ID: 17133582
[TBL] [Abstract][Full Text] [Related]
13. Relation of the International Restless Legs Syndrome Study Group rating scale with the Clinical Global Impression severity scale, the restless legs syndrome 6-item questionnaire, and the restless legs syndrome-quality of life questionnaire.
Allen R; Oertel W; Walters A; Benes H; Schollmayer E; Grieger F; Moran K; Kohnen R
Sleep Med; 2013 Dec; 14(12):1375-80. PubMed ID: 24246378
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of pramipexole in idiopathic restless legs syndrome: a polysomnographic dose-finding study--the PRELUDE study.
Partinen M; Hirvonen K; Jama L; Alakuijala A; Hublin C; Tamminen I; Koester J; Reess J
Sleep Med; 2006 Aug; 7(5):407-17. PubMed ID: 16815748
[TBL] [Abstract][Full Text] [Related]
15. Pramipexole: in restless legs syndrome.
McCormack PL; Siddiqui MA
CNS Drugs; 2007; 21(5):429-37; discussion 438-40. PubMed ID: 17447832
[TBL] [Abstract][Full Text] [Related]
16. Investigating the response to intravenous iron in restless legs syndrome: an observational study.
Hornyak M; Scholz H; Kiemen A; Kassubek J
Sleep Med; 2012 Jun; 13(6):732-5. PubMed ID: 22503006
[TBL] [Abstract][Full Text] [Related]
17. Does Improvement of Low Serum Ferritin Improve Symptoms of Restless Legs Syndrome in a Cohort of Pediatric Patients?
Rosen GM; Morrissette S; Larson A; Stading P; Barnes TL
J Clin Sleep Med; 2019 Aug; 15(8):1149-1154. PubMed ID: 31482837
[TBL] [Abstract][Full Text] [Related]
18. Reliability, validity, and responsiveness of the Japanese version of International Restless Legs Syndrome Study Group rating scale for restless legs syndrome in a clinical trial setting.
Inoue Y; Oka Y; Kagimura T; Kuroda K; Hirata K
Psychiatry Clin Neurosci; 2013 Sep; 67(6):412-9. PubMed ID: 23910574
[TBL] [Abstract][Full Text] [Related]
19. Sternberg working memory performance following treatment with pramipexole in patients with moderate-to-severe restless legs syndrome.
Jung KY; Kim SM; Song JY; Lee BU; Lee C; Lee SK; Koo YS; Cho YW; Choi JW; Kim KH
Sleep Med; 2015 Jun; 16(6):703-8. PubMed ID: 25934537
[TBL] [Abstract][Full Text] [Related]
20. Low-dose pramipexole in the management of restless legs syndrome. An open label trial.
Stiasny-Kolster K; Oertel WH
Neuropsychobiology; 2004; 50(1):65-70. PubMed ID: 15179023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
